KALA (STOCKS)
KALA BIO, Inc. Common Stock
$0.391000
-0.036600 (-8.56%)
Prev close: $0.427600
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Avi Minkowitz
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $11.02M
- Employees
- 38
- P/E (TTM)
- -0.07
- P/B (TTM)
- -0.37
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.86 | $-1.47 | +0.6144 | +41.67% |
|
Jun 2025 (Q2)
|
$-1.71 | $-1.74 | +0.0274 | +1.58% |
|
Mar 2025 (Q1)
|
$-1.41 | $-2.07 | +0.6606 | +31.90% |
|
Dec 2024 (Q4)
|
$-1.74 | $-2.33 | +0.5856 | +25.18% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $2.55M |
| Operating Expenses | $38.40M |
| Operating Income/Loss | -$38.40M |
| Income/Loss From Continuing Operations After Tax | -$35.84M |
| Income/Loss From Continuing Operations Before Tax | -$35.84M |
| Net Income/Loss | -$35.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$35.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$35.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.64 |
| Diluted Earnings Per Share | -$5.64 |
| Basic Average Shares | 6,938,071 |
| Diluted Average Shares | 6,938,071 |
| Assets | $25.02M |
| Current Assets | $24.27M |
| Noncurrent Assets | $747.00K |
| Fixed Assets | $603.00K |
| Other Non-current Assets | $144.00K |
| Liabilities | $33.69M |
| Current Liabilities | $32.57M |
| Accounts Payable | $917.00K |
| Wages | $443.00K |
| Other Current Liabilities | $31.21M |
| Noncurrent Liabilities | $1.11M |
| Long-term Debt | $26.95M |
| Equity | -$8.67M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$8.67M |
| Liabilities And Equity | $25.02M |
| Net Cash Flow From Operating Activities | -$32.03M |
| Net Cash Flow From Operating Activities, Continuing | -$32.03M |
| Net Cash Flow From Investing Activities | -$84.00K |
| Net Cash Flow From Investing Activities, Continuing | -$84.00K |
| Net Cash Flow From Financing Activities | $4.01M |
| Net Cash Flow From Financing Activities, Continuing | $4.01M |
| Net Cash Flow | -$28.11M |
| Net Cash Flow, Continuing | -$28.11M |
| Comprehensive Income/Loss | -$35.84M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$35.84M |
| Other Comprehensive Income/Loss | $0.00 |